Greenland Capital Management’s Verona Pharma VRNA Stock Holding History

Greenland Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,000	Closed	-$2.08M	–	422
2025 Q3	$2.08M	Hold	22,000	–	–	0.21%	120
2025 Q2	$2.08M	Buy	22,000 +7,000	+47%	+$518K	0.21%	124
2025 Q1	$952K	Buy	+15,000	New	+$897K	0.11%	183

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Greenland Capital Management's VRNA Position: Q4 2025 in Review

Greenland Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 22,000 shares — an estimated $2.08M sold.

Greenland Capital Management first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $2.08M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Greenland Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Greenland Capital Management sold 22,000 Verona Pharma shares in Q4 2025, an estimated $2.08M.
Greenland Capital Management first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
Greenland Capital Management's Verona Pharma position peaked at $2.08M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Greenland Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.